Home / Peptides

Also called: Thymalfasin, Zadaxin, Thymosin Alpha-1 LL-37 Nasal Stack

By The Health Stacks Research TeamUpdated September 14, 2026

Thymosin Alpha-1 is a small protein made naturally in the body. It comes from a larger part of the body called the thymus. This part of the body is very important for the immune system. Scientists study this peptide to see how it helps the body fight off sickness. It is often looked at by researchers who want to learn more about immune health.

This peptide works by acting like a switch for the immune system. It helps the body find and fight germs better. When the body is weak, this peptide might help make it stronger. It tells the immune cells to wake up and do their job. This is why many people are interested in how it helps the body stay healthy.

While it shows promise, it is not a magic cure. Research is still being done to see exactly how well it works in humans. Some studies look good, but we need more proof. It is mostly used in labs right now. People should be careful and know that it is not yet a standard medicine for everyone.

Approved*Thymosin Alpha-1 (thymalfasin) is an approved medicine in more than 35 countries — as Zadaxin, for chronic hepatitis B and C and as an immune adjuvant — but it has never been approved by the US FDA. It is not on the FDA's Section 503A Bulks List, remains an unapproved new drug under the FD&C Act, and cannot lawfully be compounded by traditional 503A pharmacies in the US. Verified confidence80–100 — backed by strong, well-corroborated sources (peer-reviewed research, clinical guidelines). Our highest confidence tier.

Regulatory status

Thymosin Alpha-1 (thymalfasin) is an approved medicine in more than 35 countries — as Zadaxin, for chronic hepatitis B and C and as an immune adjuvant — but it has never been approved by the US FDA. It is not on the FDA's Section 503A Bulks List, remains an unapproved new drug under the FD&C Act, and cannot lawfully be compounded by traditional 503A pharmacies in the US.

Status as of August 31, 2026↗ source

Benefits

What Thymosin Alpha-1 Helps With

The main themes across 153 research studies, in plain language.

Immune modulation

Immune system modulation

50/100Rated 50/100Source typeUnclassified sourceIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 112 underlying claims

Research suggests this peptide helps train and coordinate immune cells, potentially restoring balance in conditions like immunodeficiency, autoimmune disorders, and sepsis.

Research examplesBest source ↗

Vaccine response enhancement

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Clinical trials suggest it may act as an adjuvant to improve the effectiveness of vaccines, particularly in elderly populations or those with weak immune responses.

Research examplesBest source ↗

Antimicrobial & antiviral

Antiviral immune support

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 45 underlying claims

Studies indicate it may enhance the body's ability to fight viral infections, showing potential as an adjunct therapy for Hepatitis B/C, HIV, and COVID-19.

Research examplesBest source ↗

Antimicrobial defense

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 8 underlying claims

Laboratory research suggests it possesses direct or indirect antimicrobial properties, potentially enhancing the immune response against bacteria and fungi.

Research examplesBest source ↗

Cardiovascular & vascular

Cardiovascular protection

95/100Rated 95/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 25 underlying claims

Animal studies imply it supports heart health by protecting cardiac tissue after injury, promoting blood vessel formation, and improving heart function post-heart attack.

Research examplesBest source ↗

Angiogenesis & blood flow

95/100Rated 95/100Source typePeer-reviewed studyIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Research highlights its role in stimulating the formation of new blood vessels, which is critical for healing wounds and repairing damaged tissues.

Research examplesBest source ↗

Wound & tissue repair

95/100Rated 95/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 78 underlying claims

Evidence suggests it promotes the healing of skin, corneas, and internal organs by stimulating cell migration, angiogenesis, and the repair of damaged tissues.

Research examplesBest source ↗

Musculoskeletal recovery

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 15 underlying claims

Studies suggest it aids in the repair of muscle, tendons, and ligaments by activating satellite cells and promoting the structural regeneration of connective tissues.

Research examplesBest source ↗

Gastrointestinal & gut support

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 12 underlying claims

Evidence points to a potential role in maintaining the gut lining, reducing intestinal inflammation, and correcting specific functional defects in digestive disorders.

Research examplesBest source ↗

Anti-inflammatory actions

90/100Rated 90/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 42 underlying claims

Studies indicate it helps regulate inflammation by suppressing specific cytokines and signaling pathways, potentially benefiting conditions like arthritis, sepsis, and autoimmune dysregulation.

Research examplesBest source ↗

Oxidative stress reduction

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 12 underlying claims

Findings show it may decrease cellular oxidative damage by amplifying the activity of natural antioxidant enzymes like catalase and glutathione peroxidase.

Research examplesBest source ↗

Cellular defense & survival

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 28 underlying claims

Research indicates it supports cell survival under stress by regulating autophagy, inhibiting cell death pathways, and maintaining genomic stability.

Research examplesBest source ↗

Anti-fibrotic properties

90/100Rated 90/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 18 underlying claims

Research suggests it may help prevent excessive scar tissue formation in organs like the heart, liver, and lungs by modulating specific fibrotic signaling pathways.

Research examplesBest source ↗

Metabolic & glycemic support

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 8 underlying claims

Early animal studies suggest it might help regulate blood sugar levels and protect pancreatic function, though human data is limited.

Research examplesBest source ↗

Neuroprotection & repair

50/100Rated 50/100Source typeUnclassified sourceIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 22 underlying claims

Preliminary research suggests it may protect nerve cells, reduce neuroinflammation, and support recovery in models of traumatic brain injury, stroke, and neurodegenerative conditions.

Research examplesBest source ↗

Skin, hair & cosmetic

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 12 underlying claims

Research indicates it may improve skin health by reducing wrinkles, increasing elasticity, and potentially stimulating hair follicle growth.

Research examplesBest source ↗

Cancer immune adjunct

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 44 underlying claims

Research points to potential benefits in cancer care, where it may boost immune surveillance, enhance the effectiveness of chemotherapy, and improve survival rates in specific malignancies.

Research examplesBest source ↗

Free: The Peptide Stack Cheat-Sheet

You just read the research on Thymosin Alpha-1. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.

No spam. Unsubscribe anytime.

How People Use It

1 reported routine — each line links to the source it came from.

From published sources

Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.

SubQ

  • 1.6 mg (900 µg/m²) subcutaneously twice a week for 6 to 12 months 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.

Safety

Known Side Effects

Adverse effects reported in the research and by community use.

  • Local Injection Site IrritationMild 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →ncbi.nlm.nih.gov
  • Implicated in tumor metastasisSevere 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →pubmed.ncbi.nlm.nih.gov
  • Implicated in neurodegenerationSevere 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →pubmed.ncbi.nlm.nih.gov
  • Adverse drug reactionsMild 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →doi.org
  • Mild injection-site discomfort, erythema, or indurationMild 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →peptidedosage.org
  • Injection site redness and discomfortMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →rxlist.com
  • Muscle atrophyMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →rxlist.com
  • Multiple joint aches and pains (Polyarthralgia)Mild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →rxlist.com
  • Swelling and rash of the handMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →rxlist.com
  • Transient increase in ALT (flare)Moderate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →rxlist.com
  • Low-grade feverMildReported in 3 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →peptidepedia.orgpeptidepedia.orgpeptidepedia.org
  • Mild injection site reactionsMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →peptidepedia.org

Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.

Get Thymosin Alpha-1

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Technical Details (sequence & mechanism — click to expand)

Mechanism of Action

Thymosin alpha-1 (thymalfasin) is a 28-amino-acid thymic peptide immunomodulator that enhances T-cell maturation/function and dendritic-cell activity, and modulates cytokines. It is approved (as Zadaxin) in 35+ countries as an immune adjuvant for chronic hepatitis B; in the US it holds FDA orphan-drug designation only and is not FDA-approved.

Evidence

Research Citations (113)

Every claim above traces back to a source you can check — here are 113 of them.

  • Thymosin alpha 1: A comprehensive review of the literature

    Review2020 Key study 84/100Rated 84/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • FDA orphan drug designation - Thymosin Alpha-1 (Ta1)

    Guideline2023 85/100Rated 85/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • PubChem - Compound - Thymalfasin

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin alpha1: a historical overview.

    2007 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin alpha 1: A comprehensive review of the literature.

    2020 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin activity in patients with cellular immunodeficiency.

    1975 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin alpha 1: from bench to bedside.

    2007 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • From lab to bedside: emerging clinical applications of thymosin alpha 1.

    2009 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Therapeutic applications of thymosin peptides: a patent landscape 2018-present.

    2023 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.

    2025 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.

    2025 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

    2024 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

Timeline

History & Milestones

Key moments in Thymosin Alpha-1’s research and regulatory timeline — sourced and dated.

  1. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patientsPublicationDec 1, 2023
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  2. Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomesPublicationJan 1, 2023
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  3. Thymosin alpha 1: A comprehensive review of the literaturePublicationDec 15, 2020
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  4. From lab to bedside: emerging clinical applications of thymosin alpha 1PublicationMay 1, 2009
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  5. Thymosin alpha1: a historical overviewPublicationSep 1, 2007
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  6. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical applicationPublicationDec 1, 2000
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  7. Clinical applications of thymosin alpha-1.PublicationJan 1, 1994
    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

News

Latest on Thymosin Alpha-1

Dated, sourced reporting that mentions Thymosin Alpha-1.

Wondering how Thymosin Alpha-1 pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Related on The Health Stacks

Related peptides

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.